Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ)
CNY 8.97
(0.56%)
CNY 8.97
(0.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 985.01 Million | 698.97 Million | 592.17 Million | 464.79 Million | 295.62 Million | 287.49 Million |
| Net Income | 847.22 Million | 737.71 Million | 203.38 Million | 346.53 Million | 110.39 Million | 264.75 Million |
| Depreciation & Amortization | 103.05 Million | 86.57 Million | 80.95 Million | 65.98 Million | 62.36 Million | 56.16 Million |
| Deferred income taxes | -16.38 Million | 43 Million | -12.82 Million | -8.69 Million | -18.47 Million | -7.75 Million |
| Stock-based compensation | 69.79 Million | 14.73 Million | 1.2 Million | - | 2.14 Million | 7.74 Million |
| Change in working capital | -31.14 Million | -106.99 Million | -30.62 Million | 23.95 Million | -136.45 Million | -88.5 Million |
| Other non-cash items | 401.19 Million | -77.69 Million | 350.07 Million | 28.31 Million | 275.65 Million | 55.08 Million |
| Investing Cash Flow | -643.01 Million | -543.88 Million | -171.09 Million | -363.35 Million | -664.16 Million | -214.08 Million |
| Investments in PPE | -195.33 Million | -474.33 Million | -131.22 Million | -138.52 Million | -186.47 Million | -213.72 Million |
| Acquisitions | 298.46 Thousand | 2 Million | 1.76 Million | 430.38 Thousand | 3.24 Million | -9.95 Million |
| Investment purchases | -1.28 Billion | -902.11 Million | -816.49 Million | -747.37 Million | -498.39 Million | -64.4 Million |
| Sales/Maturities of investments | 838.75 Million | 822.17 Million | 742.89 Million | 508.41 Million | 5.19 Million | 51.62 Million |
| Other Investing Activities | 5.89 Million | 8.38 Million | 31.96 Million | 13.69 Million | 12.25 Million | 22.36 Million |
| Financing Cash Flow | -407.28 Million | -153.15 Million | -276.3 Million | -126.35 Million | 428.94 Million | -65.88 Million |
| Debt repayment | -3.03 Million | -3 Million | -14 Million | -14 Million | -72 Million | -50 Million |
| Dividends payments | -417.26 Million | -327.54 Million | -273.07 Million | -157.54 Million | -157.54 Million | -111.24 Million |
| Common Stock Repurchased | -2.3 Million | -40.05 Million | - | - | -140.48 Thousand | -723.53 Thousand |
| Common Stock Issuance | -7.23 Million | 37.05 Million | - | - | -2.05 Million | - |
| Other Financing Activities | 22.55 Million | 180.45 Million | 11.22 Million | 46.83 Million | 664.95 Million | 45.35 Million |
| Accounts receivables | -214.07 Million | -37.64 Million | -114.19 Million | -18.55 Million | -213.09 Million | -131.3 Million |
| Accounts payables | 131.79 Million | -75.73 Million | 123.86 Million | 82.45 Million | 122.87 Million | 71.01 Million |
| Inventory | -30.54 Million | -36.61 Million | -27.47 Million | -31.24 Million | -27.75 Million | -20.46 Million |
| Other working capital | 81.68 Million | 43 Million | -12.82 Million | -8.69 Million | -18.47 Million | -68.04 Million |
| Cash at beginning of period | 324.58 Million | 322.17 Million | 177.42 Million | 202.39 Million | 142.01 Million | 134.47 Million |
| Cash at end of period | 260.22 Million | 324.18 Million | 322.17 Million | 177.42 Million | 202.39 Million | 142.01 Million |
| Capital Expenditure | -195.33 Million | -474.33 Million | -131.22 Million | -138.52 Million | -186.47 Million | -213.72 Million |
| Effect of forex changes on cash | -107.32 Thousand | 63.09 Thousand | -14.59 Thousand | -66.96 Thousand | -29.52 Thousand | 20.8 Thousand |
| Net cash flow / Change in cash | -64.36 Million | 2 Million | 144.75 Million | -24.97 Million | 60.37 Million | 7.54 Million |
| Free Cash Flow | 789.67 Million | 224.63 Million | 460.94 Million | 326.27 Million | 109.15 Million | 73.76 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 173.58 Million | 198.38 Million | 217.74 Million | 192.81 Million | 847.22 Million | 258.05 Million |
| Depreciation & Amortization | - | 30.37 Million | 30.37 Million | 27.55 Million | 103.05 Million | -46.14 Million |
| Deferred income taxes | - | - | - | 93.14 Million | -16.38 Million | -46.7 Million |
| Stock-based compensation | - | 19.4 Million | - | 69.79 Million | 69.79 Million | -38.87 Million |
| Change in working capital | - | -177.26 Million | - | -162.93 Million | -31.14 Million | 131.37 Million |
| Other non-cash items | 49.66 Million | -102.6 Million | -56.96 Million | 122.22 Million | 401.19 Million | 35.22 Million |
| Investing Cash Flow | -88.22 Million | 282.38 Million | -102.79 Million | -348.64 Million | -643.01 Million | -310.17 Million |
| Investments in PPE | -28.46 Million | -16.94 Million | -54.39 Million | -52.49 Million | -195.33 Million | -69.19 Million |
| Acquisitions | -13.55 Million | -14.14 Million | 10.13 Million | -23.56 Million | 298.46 Thousand | 100 Thousand |
| Investment purchases | -165.18 Million | 191.62 Million | -947.57 Million | -392.28 Million | -1.28 Billion | -216.81 Million |
| Sales/Maturities of investments | 116.81 Million | 122.5 Million | 887.53 Million | 122.65 Million | 838.75 Million | -25.77 Million |
| Other Investing Activities | 2.17 Million | -645.65 Thousand | 1.51 Million | -2.95 Million | 5.89 Million | 1.51 Million |
| Financing Cash Flow | -17.73 Million | -420.75 Million | -2.19 Million | 20.51 Million | -407.28 Million | 8.14 Million |
| Debt repayment | - | -5 Million | - | -3.03 Million | -3.03 Million | -106.6 Thousand |
| Dividends payments | - | -410.95 Million | - | -417.26 Million | -417.26 Million | -2.47 Million |
| Common Stock Repurchased | 9.19 Million | -9.19 Million | - | -2.3 Million | -2.3 Million | 245.31 Thousand |
| Common Stock Issuance | - | - | - | -4.23 Million | -7.23 Million | 2.33 Million |
| Other Financing Activities | -17.73 Million | -411.23 Million | -2.19 Million | 447.36 Million | 22.55 Million | 8.14 Million |
| Accounts receivables | - | -124.44 Million | - | -214.07 Million | -214.07 Million | 105.81 Million |
| Accounts payables | - | - | - | - | 131.79 Million | 38.87 Million |
| Inventory | - | -72.22 Million | - | -30.54 Million | -30.54 Million | 25.55 Million |
| Other working capital | - | 19.4 Million | - | 81.68 Million | 81.68 Million | -38.87 Million |
| Cash at beginning of period | 241.75 Million | 316.02 Million | 260.22 Million | 266.24 Million | 324.58 Million | 253.45 Million |
| Cash at end of period | 350.78 Million | 242.33 Million | 316.02 Million | 260.22 Million | 260.22 Million | 244.12 Million |
| Capital Expenditure | -28.46 Million | -16.94 Million | -54.39 Million | -52.49 Million | -195.33 Million | -69.19 Million |
| Effect of forex changes on cash | -112.25 Thousand | 145.78 Thousand | 13.56 Thousand | 203.5 Thousand | -107.32 Thousand | -231.35 Thousand |
| Net cash flow / Change in cash | 109.02 Million | -73.69 Million | 55.8 Million | -6.01 Million | -64.36 Million | -9.33 Million |
| Free Cash Flow | 194.78 Million | 48.45 Million | 106.38 Million | 290.09 Million | 789.67 Million | 223.73 Million |
EMPPF
002596
TTW
PEBK
UNVB
SIGNATURE